Loading...

HIKAL Hikal Ltd Litigation, disputes or regulatory action Announcement

Hkl

HKL

Hikal Ltd

(HIKAL)

2025 Announcement

Summary

Summary

Director Resignation

Revised Investor Presentation

Annual Report Access

Newspaper Publication

Credit Rating Reaffirmed

FDA Warning Letter

Newspaper Publication

Earnings Call Transcript

Financial Results Publication

Earnings Call Audio

Investor Presentation

Q1 FY26 Earnings

Earnings Call Invite

GMP Certification

Transfer Requests Window

SEBI Compliance

GMP Audit Success

Annual Compliance Report

Share Transfer Update

Shareholder Reminder

FDA Inspection Update

Earnings Call Transcript

Financial Results Update

Investor Call Update

Quarterly Earnings

Investor Presentation

Board Meeting Outcomes

Earnings Conference Call

Contact Details Update

Credit Rating Reaffirmed

Compliance Certificate

Management Change

Earnings Call Transcript

TDS on Dividend

USFDA Inspection Result

Financial Results Notice

Investor Call Audio

Investor Presentation

Quarterly Results

Management Change

Earnings Conference Call

SEBI Compliance Certificate

Management Change

Management Changes

Management Change

SEBI Settlement Order

Dividend Reminder Notice

Management Change

Earnings Call Transcript

Earnings Call Transcript

Investor Meeting

Financial Results Q2

Earnings Call Update

Financial Results Q2 FY25

Investor Presentation

Earnings Call Scheduled

Regulatory Filing

Final Dividend Announcement

KYC Update Reminder

AGM Resolutions Approved

Newspaper Publication

AGM Announcement

Management Change

Financial Results Publication

Earnings Call Audio Recording

Financial Results Presentation

Financial Results Announcement

Earnings Conference Call

NGT Order Disclosure

Certificate Submission

Reminder Letter

Compliance report submission

Meeting Intimation

Earnings call outcome

Financial Results FY24

Results Presentation

Earnings Conference Call

Court Order Clarification

Postal Ballot Announcement

Compliance Certificate

Certificate Submission

Compliance Certificate

Management Change

Legal Appeal Update

Acquisition Update

Independent Directors Compl...

Directorate Change

Legal Dispute Update

Appointment of Ms. Ranjana ...

Credit Ratings Reaffirmed

Legal Dispute Resolution

Notice Publication

Appointment Announcement

Dividend Announcement

Earnings Call - Q3 & 9MFY24

Financial Results

Results Presentation

Earnings Press Release

Earnings Conference Call

Court Proceedings Stayed

Certificate Submission

Appointment of Independent ...

Appointment of Director

Supreme Court Relief

Merger Approval

Resignation of Director

Regulatory Action

BOMBAY HIGH COURT ORDER

Disclosure on Surat Incident

Publication Advertisement

SEBI Warning Letter

Financial Results

Results Presentation

Board Meeting Outcome

Conference Call

Certificate under Regulatio...

Appointment of Independent ...

Appointment of Independent ...

Advertisement Published

Newspaper Publication

Financial Statements

Disclosure of Family Agreement

Financial Statements

Financial Statements

Financial Statements

Management Changes

Equity, Debt, VC, Private E...

Earnings Call Transcript

Meetings / Presentations

Annual Secretarial Complian...

Related Party Transactions

Earnings Conference Call Re...

Financial Results Presentation

Financial Results

Regulatory Compliance

Zero Observations

External Links:

Data:

Hikal Ltd received a Warning Letter from the US FDA on August 21, 2025, citing inadequate investigations of customer complaints and vendor management deficiencies following an inspection in February 2025, which may delay revenues.

AI Assistant

Hikal Ltd

2025

Announcement

Find Answers

Ask about any part of the document to get insights, explanations, or key details.